1. Home
  2. JDZG vs ITRM Comparison

JDZG vs ITRM Comparison

Compare JDZG & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JDZG

JIADE LIMITED

HOLD

Current Price

$1.11

Market Cap

5.2M

Sector

Real Estate

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.37

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JDZG
ITRM
Founded
2020
2015
Country
China
Ireland
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
24.3M
IPO Year
2024
2018

Fundamental Metrics

Financial Performance
Metric
JDZG
ITRM
Price
$1.11
$0.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
11.1K
731.7K
Earning Date
04-17-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,680,742.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$325.95
P/E Ratio
N/A
N/A
Revenue Growth
20.36
N/A
52 Week Low
$1.11
$0.36
52 Week High
$14.00
$2.10

Technical Indicators

Market Signals
Indicator
JDZG
ITRM
Relative Strength Index (RSI) 30.29 32.72
Support Level $1.21 $0.44
Resistance Level $1.28 $0.49
Average True Range (ATR) 0.10 0.04
MACD -0.02 0.00
Stochastic Oscillator 4.95 0.78

Price Performance

Historical Comparison
JDZG
ITRM

About JDZG JIADE LIMITED

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: